ARTICLE | Clinical News
EGFR pharmDx kit regulatory update
October 9, 2006 7:00 AM UTC
FDA approved a PMA for Dako's EGFR pharmDx kits to assess patient eligibility for Vectibix to treat colorectal cancer. Vectibix panitumumab is marketed by Amgen Inc. (AMGN, Thousand Oaks, Calif.). D...